Standard name |
TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP |
Systematic name |
M2212 |
Brief description |
Candidate genes in the regions of copy number gain in gastric cancer cell lines. |
Full description or abstract |
Array-based comparative genomic hybridization (CGH-array) has a powerful potential for high-throughput identification of genetic aberrations in cell genomes. We identified a homozygous loss of ADAM23 (2q33.3) in the course of a program to screen a panel of gastric cancer (GC) cell lines (1/32, 3.1%) for genomic copy-number aberrations using our custom-made CGH-array. Infrequent homozygous deletion of ADAM23 was also seen in primary gastric tumors (1/39, 2.6%). ADAM23 mRNA was expressed in normal stomach tissue, but not in the majority of GC cell lines without homozygous deletion of this gene. Expression of ADAM23 mRNA was restored to gene-silenced GC cells after treatment with 5-aza 2'-deoxycytidine. The methylation status of the ADAM23 CpG island, which showed promoter activity, correlated inversely with its expression. Methylation of this CpG island was observed both in GC cell lines and in primary GC tissues; in primary tumors with a hypermethylated CpG island, expression of ADAM23 was lower than in adjacent noncancerous tissues. Moreover, restoration of ADAM23 in GC cells reduced their numbers in colony-formation assays. These results suggest that genetic or epigenetic silencing by hypermethylation of the ADAM23 CpG-rich promoter region leads to loss of ADAM23 function, which may be a factor in gastric carcinogenesis. |
Collection |
C2: Curated CGP: Chemical and Genetic Perturbations |
Source publication |
Pubmed 16103878 Authors: Takada H,Imoto I,Tsuda H,Nakanishi Y,Ichikura T,Mochizuki H,Mitsufuji S,Hosoda F,Hirohashi S,Ohki M,Inazawa J |
Exact source |
Table 1 |
Related gene sets |
(show 1 additional gene sets from the source publication)
(show 13 gene sets from the same authors)
|
External links |
|
Filtered by similarity ?
|
|
Source species |
Homo sapiens |
Contributed by |
Arthur Liberzon (MSigDB Team) |
Source platform or identifier namespace |
HUMAN_GENE_SYMBOL |
Dataset references |
|
Download gene set |
format: grp | gmt | xml | json | TSV metadata |
Compute overlaps ? |
(show collections to investigate for overlap with this gene set)
|
Compendia expression profiles ? |
NG-CHM interactive heatmaps
(Please note that clustering takes a few seconds)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
Legacy heatmaps (PNG)
GTEx compendium
Human tissue compendium (Novartis)
Global Cancer Map (Broad Institute)
NCI-60 cell lines (National Cancer Institute)
|
Advanced query |
Further investigate
these 7 genes
|
Gene families ? |
Categorize these
7 genes by gene family
|
Show members |
(show 7 source identifiers mapped to 7 genes)
Source Id |
NCBI (Entrez) Gene Id |
Gene Symbol |
Gene Description |
FGFR2 |
2263 |
FGFR2 |
fibroblast growth factor receptor 2 [Source:HGNC... |
KRAS |
3845 |
KRAS |
KRAS proto-oncogene, GTPase [Source:HGNC Symbol;... |
MET |
4233 |
MET |
MET proto-oncogene, receptor tyrosine kinase [So... |
MYBL2 |
4605 |
MYBL2 |
MYB proto-oncogene like 2 [Source:HGNC Symbol;Ac... |
MYC |
4609 |
MYC |
MYC proto-oncogene, bHLH transcription factor [S... |
SDC1 |
6382 |
SDC1 |
syndecan 1 [Source:HGNC Symbol;Acc:HGNC:10658] |
SSPN |
8082 |
SSPN |
sarcospan [Source:HGNC Symbol;Acc:HGNC:11322] |
|
Version history |
|